General Medicine Interest Group
千葉大学医学部医の学生が主体となり、身体診察スキルとトレーニングする学部公認のサークルです。全8回のセッションを半期で行います。興味のある方は、ご一報ください。
連絡先:千葉大学医学部附属病院 総合診療科 鋪野紀好
メール:kshikino@gmail.com
General Medicine Interest Group
千葉大学医学部医の学生が主体となり、身体診察スキルとトレーニングする学部公認のサークルです。全8回のセッションを半期で行います。興味のある方は、ご一報ください。
連絡先:千葉大学医学部附属病院 総合診療科 鋪野紀好
メール:kshikino@gmail.com
5. 下痢の定義とは
“Diarrhoea is the passage of 3 or more loose or
liquid stools per day, or more frequently than is
normal for the individual. It is usually a symptom of
gastrointestinal infection, which can be caused by a
variety of bacterial, viral and parasitic organisms.
Infection is spread through contaminated food or
drinking-water, or from person to person as a result
of poor hygiene.”
10. その他
(1)MuddyROAD TRAVEL with Family(非感染性下痢)
Milk and ?uctose allergy/Drugs/Roentogen therapy/Ope/
AIDS/Alchohol/DM/Travel/Irritable bowel/Family history of
IBD
(2)DATSUN(よくある薬剤)
Diuretics/Anti-acids,Anti-arrythmia/Theophilline/Softner/
NSAIDS
(3)24-7-365 at CT(画像検索が必要なことも)
Carcinoids/Carcinoma/Thyroid inbalance
22. Fig. 2: Factors contributing to the development of Clostridium difficile colonization and diarrhea
[adapted, with permission, from Johnson S, Gerding DN. Clostridium difficile-associated diarrhea.
Poutanen S M , Simor A E CMAJ 2004;171:51-58
?2004 by Canadian Medical Association
40. Current Concepts 治療について3
mycin was re-
ses in the in-
ection during 100 98%
Vancomycin Metronidazole
97%
重症
nts remain the 90%
90
patients with
年齢 60歳以上
Response Rate (%)
ntrolled trials 80 76%
ducted before
mulative fail-
38.3℃以上
70
nidazole and 体温
60
.5% and 3.5%,
substantially
2.5g/dl以下
50
rted for met- アルブミン
0
xample, in the Mild Infection Severe Infection
uebec, 26% of
o metronida-
Figure 3. Response Rates to Vancomycin and Metroni-
AUTHOR: Kelly RETAKE
dazole Therapy, According to the Severity of C. difficile
ICM
1st
Cre 1.5以上
tudy also re- Infection. FIGURE: 3 of 4
REG F
2nd
3rd
of diarrhea in Patients with C. difficile infection were randomly as-
15000以上
CASE Revised
metronidazole Line
signed to receive therapy with either 4-C vancomycin
oral 白血球
N Engl J Med 2008;359 1932-40
EMail SIZE
ARTIST: ts H/T daily) or metronidazole
H/T
e treated with (at a dose of 125 mg four times
Enon
Combo
16p6
1).22 (at a dose of 250 mg four times daily) after stratifica-
AUTHOR, PLEASE NOTE:
tion according tobeen redrawn and type has been reset. was
Figure has disease severity. Severe infection
debate as to defined according to the check carefully.
Please presence of pseudomembra-
metronidazole nous colitis on endoscopy, admission to an intensive
tion. Recom-
essional soci- 推奨量は通常よりも高容量(500mgx4回/日)
care unit, or any two of the following factors: an age
JOB: 35918 ISSUE: 10-30-08
of more than 60 years, a temperature above 101°F
(38.3°C), a serum albumin level of less than 2.5 g per
rst-line agent
deciliter, and a white-cell count of more than 15,000
since a small cells per cubic millimeter. The difference in response
al in patients rates between vancomycin and metronidazole was not
46. 移植!?
new england
The
journal of medicine
established in 1812 january 31, 2013 vol. 368 no. 5
Duodenal Infusion of Donor Feces for Recurrent
Clostridium difficile
Els van Nood, M.D., Anne Vrieze, M.D., Max Nieuwdorp, M.D., Ph.D., Susana Fuentes, Ph.D.,
Erwin G. Zoetendal, Ph.D., Willem M. de Vos, Ph.D., Caroline E. Visser, M.D., Ph.D., Ed J. Kuijper, M.D., Ph.D.,
Joep F.W.M. Bartelsman, M.D., Jan G.P. Tijssen, Ph.D., Peter Speelman, M.D., Ph.D.,
Marcel G.W. Dijkgraaf, Ph.D., and Josbert J. Keller, M.D., Ph.D.
A bs t r ac t
ランチタイムの抄読会に是非!
Background